TSM stock is near a buy point after gapping up on a "blowout quarter" on Oct. 17. The stock is on the IBD global leaders list ...

The first recommendation emphasizes the importance of a Mediterranean diet unless contraindicated. This diet, which ...

Orphagen Pharmaceuticals, Inc., a biotech company pioneering the screening, discovery, and development of small molecule ligands that modulate orphan or unexplored members of the nuclear receptor ...

AppLovin is just one of three "aptly" named highflying growth stocks. Palantir stock also joins this list top stocks in top ...

Controlling intestinal inflammation for 12-month periods reduced fracture risk in patients with inflammatory bowel disease, ...

Sanjay K. Murthy, MD, MSc (Epid), talked with Physician’s Weekly about changes in digestive cancer types among patients with ...

Takeda Canada Inc. (Takeda) congratulates the recipients of the Canadian Inflammatory Bowel Disease Research Consortium (CIRC) $1 million PIONEER Grant to support innovative, high-quality Canadian ...

NET PROFIT: The Chinese food-delivery company will likely report net profit of 10.20 billion yuan, equivalent to $1.41 billion, according to the consensus estimate of nine analysts polled by FactSet.

AI for IBD is gradually improving clinical care for gastroenterologists, but it comes with challenges, such as cost and ...